scholarly journals FlexiBAC: a versatile, open-source baculovirus vector system for protein expression, secretion, and proteolytic processing

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Régis P. Lemaitre ◽  
Aliona Bogdanova ◽  
Barbara Borgonovo ◽  
Jeffrey B. Woodruff ◽  
David N. Drechsel
2019 ◽  
Vol 19 (1) ◽  
pp. 7-19 ◽  
Author(s):  
Xiao-Xiao Lu ◽  
Shao-Zhen Zhao

Background: As one of the main blinding ocular diseases, corneal blindness resulted from neovascularization that disrupts the angiogenic privilege of corneal avascularity. Following neovascularization, inflammatory cells are infiltrating into cornea to strengthen corneal injury. How to maintain corneal angiogenic privilege to treat corneal disease has been investigated for decades. Methodology: Local administration of viral and non-viral-mediated anti-angiogenic factors reduces angiogenic protein expression in situ with limited or free of off-target effects upon gene delivery. Recently, Mesenchymal Stem Cells (MSCs) have been studied to treat corneal diseases. Once MSCs are manipulated to express certain genes of interest, they could achieve superior therapeutic efficacy after transplantation. Discussion: In the text, we first introduce the pathological development of corneal disease in the aspects of neovascularization and inflammation. We summarize how MSCs become an ideal candidate in cell therapy for treating injured cornea, focusing on cell biology, property and features. We provide an updated review of gene-based therapies in animals and preclinical studies in the aspects of controlling target gene expression, safety and efficacy. Gene transfer vectors are potent to induce candidate protein expression. Delivered by vectors, MSCs are equipped with certain characters by expressing a protein of interest, which facilitates better for MSC-mediated therapeutic intervention for the treatment of corneal disease. Conclusion: As the core of this review, we discuss how MSCs could be engineered to be vector system to achieve enhanced therapeutic efficiency after injection.


2014 ◽  
Vol 56 (11) ◽  
pp. 963-970 ◽  
Author(s):  
V. Ruiz ◽  
A. C. Mignaqui ◽  
M. C. Nuñez ◽  
E. Reytor ◽  
J. M. Escribano ◽  
...  

Plant Methods ◽  
2013 ◽  
Vol 9 (1) ◽  
pp. 28 ◽  
Author(s):  
Huaibi Zhang ◽  
Lei Wang ◽  
Donald Hunter ◽  
Charlotte Voogd ◽  
Nigel Joyce ◽  
...  

2002 ◽  
Vol 64 (2) ◽  
pp. 95-100 ◽  
Author(s):  
Kazuaki TAKEHARA ◽  
Makiyo KAMIKAWA ◽  
Naomi OHNUKI ◽  
Tomoshi NAGATA ◽  
Ayako NAKANO ◽  
...  

2018 ◽  
Author(s):  
Régis P. Lemaitre ◽  
Aliona Bogdanova ◽  
Barbara Borgonovo ◽  
Jeffrey B. Woodruff ◽  
David N. Drechsel

ABSTRACTBaculovirus-mediated expression in insect cells is a powerful approach for protein production. However, many existing methods are time consuming, offer limited options for protein tagging, and are unsuitable for secreted proteins requiring proteolytic maturation, such as TGF-β family growth factors. To overcome these limitations, we engineered “FlexiBAC”, a system that simplifies baculovirus production and permits furin-driven proteolytic maturation of targets. This system allows recombinant baculovirus formation inside insect cells and reduces the time between initial cloning and protein production to 13 days. FlexiBAC includes 146 shuttle vectors that append combinations of purification tags, fluorescent markers, proteolytic cleavage sites, trafficking signals, and chemical conjugation tags to the termini of the target protein. We demonstrate that this system can be used to produce high levels of mature, active forms of TGF-β family growth factors, such as Activin A, as well as other proteins that are typically difficult to reconstitute, such as proteins rich in coiled-coil, low complexity, and disordered domains.


Sign in / Sign up

Export Citation Format

Share Document